Skip to main content
. 2012 Nov;19(11):1722–1729. doi: 10.1128/CVI.00315-12

Table 1.

Description of experimental treatment groupsa

Group Vaccine Challenge virus No. of mice in group
Ad5-empty/NC Ad5-empty Sham 8
Ad5-empty/CA09 Ad5-empty CA09 8
Ad5-empty/MN08 Ad5-empty MN08 8
Ad5-HA/CA09 Ad5-HA CA09 7
Ad5-HA/MN08 Ad5-HA MN08 8
kaCA/MN08 kaCA MN08 8
a

NC, nonchallenged; CA09, A/CA/04/09; MN08, A/swine/MN/2011/08; HA, codon-optimized HA from A/CA/04/09; kaCA, killed, adjuvanted CA09.